Label: Information for the Patient
Sedaconda 100% Liquid for Inhalation of Vapor
isoflurane
Read the entire label carefully before starting to use this medication, as it contains important information for you.
- If you experience any adverse effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this label. See Section 4.
This medication contains the active substance isoflurane which belongs to a group of medicines called anesthetics. It is used to provide sedation (a state of calmness, drowsiness or sleep) in adult patients who require mechanical ventilation (a treatment with special equipment that helps patients breathe) during their admission to intensive care.
No use Sedaconda
Warnings and precautions
Consult your doctor or nurse before starting to use this medication if:
Sedaconda may cause malignant hyperthermia, a rapid and significant rise in body temperature accompanied by muscle rigidity and other symptoms (see section 4).
Sedaconda may cause hyperkalemia (elevated serum potassium levels) in rare cases (see section 4). Patients with neuromuscular disease appear to be the most vulnerable.
Sedaconda may cause respiratory depression (see section 4).
Children and adolescents
This medication should not be administered to children and adolescents under 18 years of age, as experience with this medication is limited in this age group.
Other medications and Sedaconda
Inform your doctor or nurse if you are taking, have taken recently, or may need to take any other medication.
This is particularly important if you are taking any of the following medications:
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medication.
Sedaconda may cause increased blood loss, for example if you are undergoing a uterine operation, or if you are giving birth. Your doctor will not give you this medication unless the potential benefits outweigh the potential risks for you and your baby.
If you have been breastfeeding before receiving Sedaconda, you should stop breastfeeding until the medication has been eliminated from your body. Your doctor will inform you when it is safe for you to continue breastfeeding.
Driving and operating machinery
This medication may affect your ability to drive and operate machinery for up to 6 days.
You should not drive or operate machinery until your doctor advises it is safe to do so.
Sedaconda will only be administered by qualified and experienced medical personnel. The doctor will decide on the appropriate dose for you based on your age, health condition, and the level of sedation (drowsiness) you need.
The doctor will give you the initial correct dose to achieve the required level of sedation while closely monitoring your responses and vital signs (such as pulse, blood pressure, and breathing, etc.).
Sedaconda is a liquid that changes to vapor (gas) with the use of a vaporizer. It is for inhalation use, meaning you will breathe it in as a vapor.
If you receive more Sedaconda than you should
If you are given too much Sedaconda and are in deep sedation, your blood pressure may drop (hypotension) and your breathing may be slow and ineffective. The doctor will take supportive measures to correct your blood pressure and breathing.
If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Unknown frequency side effects (cannot be estimated from available data):
Frequent side effects reported in a clinical trial (may affect up to 1 in 10 people):
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this prospectus. You can also report them directly through the Spanish System of Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box and on the bottle label after CAD. The expiration date is the last day of the month indicated.
Sedaconda expirationafter attaching it to the Sedaconda Filling Adapter is 14 days.
Do not store above 86°F (30°C). Store the bottle in the outer packaging to protect it from light.
The disposal of unused medication and all materials that have been in contact with it, will be carried out in accordance with local regulations.
Composition of Sedaconda
Appearance of the product and contents of the container
Sedaconda is a vapor inhalation liquid. It is a colorless and transparent liquid, available in amber glass bottles of 100 ml and 250 ml.
Container sizes:
6 x 100 ml
6 x 250 ml
Only some container sizes may be commercially available
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Sedana Medical AB
Svärdvägen 3ASE-182 33 Danderyd
Sweden
Responsible for manufacturing
Piramal Critical Care B.V.
Rouboslaan 32 (ground floor)
2252 TR, Voorschoten
Netherlands
Local representative:
SEDANA MEDICAL AB SUCURSAL EN ESPAÑA,
Calle Edgar Neville, 27
28020, Madrid
Spain
This medicine is authorized in the member states of the European Economic Area with the following names:
Sedaconda:Germany, Belgium, Croatia, Denmark, Slovenia, Spain, Finland, Ireland, Italy, Norway, Netherlands, Poland, Portugal and Sweden.
Cedaconda:Austria, France
Date of the last review of this leaflet:September 2022
------------------------------------------------------------------------------------------------------------------------
This information is intended solely for healthcare professionals:
Sedaconda 100% vapor inhalation liquid
Administration
Sedaconda should only be administered and inhaled through the Sedaconda ACD (Anesthetic Conservation Device) using the Sedaconda Filling Adapter and should only be used with intubated or tracheotomized patients with protected airways. Sedaconda should only be administered by medical personnel familiar with the management of patients with mechanical ventilation, Sedaconda ACD, and the pharmacodynamics of isoflurane.
Isoflurane should only be administered in a suitably equipped environment, by personnel trained in the handling of volatile anesthetic agents.
SedacondaACDis a modified passive heat and humidity exchanger (HME) and as such adds dead space to the respiratory circuit. The patient's ventilatory status should be taken into account when selecting the size of SedacondaACD, consult the Instructions for Use provided with SedacondaACD.
For complete information on how to use SedacondaACDand the Sedaconda Filling Adapter, see the Instructions for Use provided with the devices.
Read the Sedaconda technical data sheet and the Instructions for Use provided with SedacondaACDand the Sedaconda Filling Adapter before configuring the SedacondaACDadministration system and initiating sedation.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.